Schrödinger, Inc. provided earnings guidance for the fiscal year 2022. For the period, the company expects revenue to be in the range from $167 million to $175 million, compared to the prior expectation of $161 million to $181 million. The updated range represents growth of 21% to 27% over 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.11 USD | +0.59% | +0.32% | -38.24% |
May. 13 | Ajax Therapeutics, Inc. announced that it has received $95 million in funding from a group of investors | CI |
May. 07 | Ansys Partners With Schrodinger to Accelerate Materials Development | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.24% | 1.61B | |
+14.43% | 3,198B | |
+14.18% | 90.08B | |
+8.75% | 80.61B | |
-13.94% | 54.83B | |
+22.60% | 46.88B | |
+32.14% | 46.51B | |
-30.71% | 42.9B | |
+71.93% | 39.99B | |
-2.58% | 26.87B |
- Stock Market
- Equities
- SDGR Stock
- News Schrödinger, Inc.
- Schrödinger, Inc. Provides Earnings Guidance for the Fiscal Year 2022